{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:26:41Z","timestamp":1790270801599,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004008","name":"National Institute of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004008","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ejphar.2021.173988","type":"journal-article","created":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T11:14:38Z","timestamp":1614683678000},"page":"173988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19"],"prefix":"10.1016","volume":"898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5880-275X","authenticated-orcid":false,"given":"Bertram","family":"Pitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0968-3085","authenticated-orcid":false,"given":"Nadia R.","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha N.","family":"Goonewardena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5100-1933","authenticated-orcid":false,"given":"Michael","family":"Holinstat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.173988_bib1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pediatrneurol.2009.06.003","article-title":"Metabolic alterations during valproic acid treatment: a prospective study","volume":"41","author":"Abaci","year":"2009","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ejphar.2021.173988_bib2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2021.173988_bib3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/pds.3761","article-title":"Safety of valproic acid in patients with chronic obstructive pulmonary disease: a population-based cohort study","volume":"24","author":"Antoniou","year":"2015","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"16","key":"10.1016\/j.ejphar.2021.173988_bib4","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jama.2020.4326","article-title":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state","volume":"323","author":"Arentz","year":"2020","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ejphar.2021.173988_bib5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/MBC.0000000000000626","article-title":"Valproic acid modulates platelet and coagulation function ex vivo","volume":"28","author":"Bambakidis","year":"2017","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"19","key":"10.1016\/j.ejphar.2021.173988_bib6","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of covid-19 - preliminary report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2021.173988_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/CRST.CRST_156_20","article-title":"Repurposing valproate to prevent acute respiratory distress syndrome\/acute lung injury in COVID-19: a review of immunomodulatory action","volume":"3","author":"Bhargava","year":"2020","journal-title":"Cancer Res Stat Treat"},{"key":"10.1016\/j.ejphar.2021.173988_bib8","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review","volume":"75","author":"Bikdeli","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.ejphar.2021.173988_bib9","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/jama.2020.13372","article-title":"Thrombosis in hospitalized patients with COVID-19 in a New York city Health system","volume":"324","author":"Bilaloglu","year":"2020","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ejphar.2021.173988_bib10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/STROKEAHA.117.016674","article-title":"Sodium valproate, a histone deacetylase inhibitor, is associated with reduced stroke risk after previous ischemic stroke or transient ischemic attack","volume":"49","author":"Brookes","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2021.173988_bib11","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/CIRCULATIONAHA.120.047419","article-title":"Will complement inhibition Be the new target in treating COVID-19-related systemic thrombosis?","volume":"141","author":"Campbell","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2021.173988_bib12","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.jvs.2011.08.060","article-title":"Valproic acid reversed pathologic endothelial cell gene expression profile associated with ischemia-reperfusion injury in a swine hemorrhagic shock model","volume":"55","author":"Causey","year":"2012","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.ejphar.2021.173988_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126028","article-title":"Protective effects of valproic acid, a histone deacetylase inhibitor, against hyperoxic lung injury in a neonatal rat model","volume":"10","author":"Cetinkaya","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2021.173988_bib14","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","article-title":"Kidney disease is associated with in-hospital death of patients with COVID-19","volume":"97","author":"Cheng","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2021.173988_bib15","series-title":"Possible Inhibitors of ACE2, the Receptor of 2019-nCoV","author":"Cui","year":"2020"},{"key":"10.1016\/j.ejphar.2021.173988_bib16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/ckj\/sfaa104","article-title":"Coronavirus disease 2019 in chronic kidney disease","volume":"13","author":"D'Marco","year":"2020","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ejphar.2021.173988_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/diseases6030059","article-title":"Valproic acid downregulates cytokine expression in human macrophages infected with Dengue virus","volume":"6","author":"Delgado","year":"2018","journal-title":"Diseases"},{"key":"10.1016\/j.ejphar.2021.173988_bib18","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/pds.3651","article-title":"Is sodium valproate, an HDAC inhibitor, associated with reduced risk of stroke and myocardial infarction? A nested case-control study","volume":"23","author":"Dregan","year":"2014","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.ejphar.2021.173988_bib19","first-page":"111","article-title":"Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells","volume":"39","author":"Fortson","year":"2011","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejphar.2021.173988_bib20","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/CIRCULATIONAHA.120.047164","article-title":"The variety of cardiovascular presentations of COVID-19","volume":"141","author":"Fried","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ejphar.2021.173988_bib21","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1212\/WNL.0000000000010979","article-title":"A prospective study of neurologic disorders in hospitalized COVID-19 patients in New York city","volume":"96","author":"Frontera","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2021.173988_bib22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1517\/14656566.9.2.285","article-title":"Oral valproic acid for epilepsy--long-term experience in therapy and side effects","volume":"9","author":"Gerstner","year":"2008","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.ejphar.2021.173988_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00535-006-1961-4","article-title":"Valproic acid-induced pancreatitis: 16 new cases and a review of the literature","volume":"42","author":"Gerstner","year":"2007","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2021.173988_bib24","doi-asserted-by":"crossref","first-page":"104362","DOI":"10.1016\/j.jcv.2020.104362","article-title":"Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past","volume":"127","author":"Giannis","year":"2020","journal-title":"J. Clin. Virol."},{"issue":"8","key":"10.1016\/j.ejphar.2021.173988_bib25","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","article-title":"Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study","volume":"7","author":"Goshua","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.ejphar.2021.173988_bib26","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2214\/ajr.148.3.501","article-title":"Pulmonary vascular obstruction in severe ARDS: angiographic alterations after i.v. fibrinolytic therapy","volume":"148","author":"Greene","year":"1987","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ejphar.2021.173988_bib27","series-title":"Microthrombi and ST-segment elevation myocardial infarction in COVID-19","author":"Guagliumi","year":"2020"},{"issue":"7","key":"10.1016\/j.ejphar.2021.173988_bib28","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ejphar.2021.173988_bib29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2021.173988_bib30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jphs.2018.10.004","article-title":"Anti-angiogenic effects of valproic acid in a mouse model of oxygen-induced retinopathy","volume":"138","author":"Iizuka","year":"2018","journal-title":"J. Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.ejphar.2021.173988_bib31","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/jamacardio.2020.1096","article-title":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Inciardi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ejphar.2021.173988_bib32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12985-016-0626-z","article-title":"Valproic acid ameliorates coxsackievirus-B3-induced viral myocarditis by modulating Th17\/Treg imbalance","volume":"13","author":"Jin","year":"2016","journal-title":"Virol. J."},{"key":"10.1016\/j.ejphar.2021.173988_bib33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fpubh.2020.00152","article-title":"Gender differences in patients with COVID-19: focus on severity and mortality","volume":"8","author":"Jin","year":"2020","journal-title":"Front Public Health"},{"key":"10.1016\/j.ejphar.2021.173988_bib34","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.intimp.2016.08.008","article-title":"Amelioration of bleomycin-induced lung fibrosis in rats by valproic acid and butyrate: role of nuclear factor kappa-B, proinflammatory cytokines and oxidative stress","volume":"39","author":"Kabel","year":"2016","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejphar.2021.173988_bib35","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1124\/mol.114.096974","article-title":"Histone deacetylase inhibition attenuates cardiac hypertrophy and fibrosis through acetylation of mineralocorticoid receptor in spontaneously hypertensive rats","volume":"87","author":"Kang","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.173988_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCULATIONAHA.105.559724","article-title":"Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding","volume":"113","author":"Kee","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2021.173988_bib37","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.yexmp.2015.01.003","article-title":"Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the inhibition of histone deacetylases in diabetic rat","volume":"98","author":"Khan","year":"2015","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.ejphar.2021.173988_bib38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.biochi.2016.02.014","article-title":"Valproic acid reduces insulin-resistance, fat deposition and FOXO1-mediated gluconeogenesis in type-2 diabetic rat","volume":"125","author":"Khan","year":"2016","journal-title":"Biochimie"},{"key":"10.1016\/j.ejphar.2021.173988_bib39","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.thromres.2020.04.041","article-title":"Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ejphar.2021.173988_bib40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ejphar.2021.173988_bib41","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1111\/j.1528-1167.2006.00846.x","article-title":"Valproic acid-induced hepatopathy: nine new fatalities in Germany from 1994 to 2003","volume":"47","author":"Koenig","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2021.173988_bib42","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1172\/JCI19137","article-title":"Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop","volume":"112","author":"Kook","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2021.173988_bib43","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1136\/thoraxjnl-2014-206411","article-title":"Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis","volume":"70","author":"Korfei","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.ejphar.2021.173988_bib44","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/jth.13527","article-title":"Valproic acid selectively increases vascular endothelial tissue-type plasminogen activator production and reduces thrombus formation in the mouse","volume":"14","author":"Larsson","year":"2016","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.ejphar.2021.173988_bib45","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/CIRCRESAHA.113.301071","article-title":"Histone deacetylase inhibition attenuates transcriptional activity of mineralocorticoid receptor through its acetylation and prevents development of hypertension","volume":"112","author":"Lee","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2021.173988_bib46","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/22221751.2020.1741327","article-title":"Clinical observation and management of COVID-19 patients","volume":"9","author":"Li","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.ejphar.2021.173988_bib47","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1158\/2159-8290.CD-13-1010","article-title":"The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis","volume":"4","author":"Lucas","year":"2014","journal-title":"Canc. Discov."},{"key":"10.1016\/j.ejphar.2021.173988_bib48","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/hep.23334","article-title":"Chronic administration of valproic acid inhibits activation of mouse hepatic stellate cells in vitro and in vivo","volume":"51","author":"Mannaerts","year":"2010","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.ejphar.2021.173988_bib49","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood.2020007214","article-title":"Platelet gene expression and function in COVID-19 patients","volume":"136","author":"Manne","year":"2020","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.ejphar.2021.173988_bib50","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.jaccas.2020.04.023","article-title":"Takotsubo syndrome in the setting of COVID-19 infection","volume":"2","author":"Minhas","year":"2020","journal-title":"JACC Case Rep"},{"key":"10.1016\/j.ejphar.2021.173988_bib51","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/pds.2186","article-title":"Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: a nationwide cohort study","volume":"20","author":"Olesen","year":"2011","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.ejphar.2021.173988_bib52","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/jth.14850","article-title":"Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis","volume":"18","author":"Panigada","year":"2020","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.ejphar.2021.173988_bib53","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1161\/01.RES.0000150734.79804.92","article-title":"Cytokine-induced modulation of cardiac function","volume":"95","author":"Prabhu","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2021.173988_bib54","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fendo.2017.00147","article-title":"Does valproic acid have potential in the treatment of diabetes mellitus?","volume":"8","author":"Rakitin","year":"2017","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejphar.2021.173988_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107582","article-title":"Profibrinolytic effect of the epigenetic modifier valproic acid in man","volume":"9","author":"Saluveer","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2021.173988_bib56","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.007071","article-title":"HDAC (histone deacetylase) inhibitor valproic acid attenuates atrial remodeling and delays the onset of atrial fibrillation in mice","volume":"12","author":"Scholz","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ejphar.2021.173988_bib57","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.2337\/dc20-0598","article-title":"Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in wuhan, China: a two-center, retrospective study","volume":"43","author":"Shi","year":"2020","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.ejphar.2021.173988_bib58","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in wuhan, China","volume":"5","author":"Shi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ejphar.2021.173988_bib59","doi-asserted-by":"crossref","first-page":"12552","DOI":"10.1128\/JVI.01890-13","article-title":"Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2","volume":"87","author":"Shirato","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2021.173988_bib60","first-page":"138","article-title":"Valproic acid in prevention and treatment of COVID-19","volume":"7","author":"Singh","year":"2020","journal-title":"Int J Respir Pulm Med"},{"key":"10.1016\/j.ejphar.2021.173988_bib61","doi-asserted-by":"crossref","first-page":"9678098","DOI":"10.1155\/2019\/9678098","article-title":"Exploring the drug repurposing versatility of valproic acid as a multifunctional regulator of innate and adaptive immune cells","volume":"2019","author":"Soria-Castro","year":"2019","journal-title":"J Immunol Res"},{"key":"10.1016\/j.ejphar.2021.173988_bib62","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.kint.2020.04.003","article-title":"Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China","volume":"98","author":"Su","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2021.173988_bib63","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3892\/mmr.2015.4580","article-title":"Valproate attenuates diabetic nephropathy through inhibition of endoplasmic reticulum stressinduced apoptosis","volume":"13","author":"Sun","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2021.173988_bib64","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s13105-011-0088-0","article-title":"Wfs1 mutation makes mice sensitive to insulin-like effect of acute valproic acid and resistant to streptozocin","volume":"67","author":"Terasmaa","year":"2011","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.ejphar.2021.173988_bib65","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ebiom.2018.12.003","article-title":"HDAC inhibitor valproic acid protects heart function through Foxm1 pathway after acute myocardial infarction","volume":"39","author":"Tian","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejphar.2021.173988_bib66","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1474-4422(18)30107-8","article-title":"Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry","volume":"17","author":"Tomson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2021.173988_bib67","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1053\/sarh.2002.28303","article-title":"Viral infections and antiphospholipid antibodies","volume":"31","author":"Uthman","year":"2002","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2021.173988_bib68","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1681\/ASN.2010111196","article-title":"Valproic acid attenuates proteinuria and kidney injury","volume":"22","author":"Van Beneden","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2021.173988_bib69","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2021.173988_bib70","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/JVI.01717-10","article-title":"Inhibition of enveloped virus infection of cultured cells by valproic acid","volume":"85","author":"Vazquez-Calvo","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2021.173988_bib71","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137799","article-title":"The laboratory tests and host immunity of COVID-19 patients with different severity of illness","volume":"5","author":"Wang","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejphar.2021.173988_bib72","first-page":"648","article-title":"Lithium and valproate acid protect NSC34 cells from H2O2-induced oxidative stress and upregulate expressions of SIRT3 and CARM1","volume":"34","author":"Wang","year":"2013","journal-title":"Neuroendocrinol. Lett."},{"issue":"7821","key":"10.1016\/j.ejphar.2021.173988_bib73","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"OpenSAFELY: factors associated with COVID-19 death in 17 million patients","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2021.173988_bib74","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1089\/dna.2011.1401","article-title":"Histone deacetylase inhibition by sodium valproate regulates polarization of macrophage subsets","volume":"31","author":"Wu","year":"2012","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.ejphar.2021.173988_bib75","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/CIRCULATIONAHA.120.046702","article-title":"Deep vein thrombosis in hospitalized patients with COVID-19 in wuhan, China: prevalence, risk factors, and outcome","volume":"142","author":"Zhang","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2021.173988_bib76","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and antiphospholipid antibodies in patients with covid-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2021.173988_bib77","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s12094-016-1494-0","article-title":"Valproic acid inhibits the angiogenic potential of cervical cancer cells via HIF-1 alpha\/VEGF signals","volume":"18","author":"Zhao","year":"2016","journal-title":"Clin. Transl. Oncol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921001412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921001412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:47:34Z","timestamp":1757976454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299921001412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":77,"alternative-id":["S0014299921001412"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.173988","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.173988","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173988"}}